Bayer | BAYN - Equity Capital And Reserves



Bayer reported EUR30.5B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Air Liquide EUR 24.51B 3.11B Jun/2025
Akzo Nobel EUR 4.17B 452M Jun/2025
Alcon AG USD 22.13B 111M Jun/2025
Amarin USD 473.69M 12.49M Mar/2025
Arkema EUR 6.13B 1.23B Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
BASF EUR 32.36B 3.73B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Beiersdorf EUR 8.47B 7M Jun/2025
Corteva USD 25.91B 1.62B Jun/2025
Covestro EUR 6.15B 255M Jun/2025
Essilor EUR 37.82B 3.18B Jun/2025
Fresenius EUR 18.94B 465M Jun/2025
Fresenius Medical Care EUR 14.33B 1.18B Jun/2025
Genmab DKK 5.3B 6M Jun/2025
Givaudan CHF 4.31B 320M Jun/2024
GlaxoSmithKline GBP 14.35B 197M Jun/2025
GRIFOLS EUR 7.6B 1.96B Jun/2025
Henkel EUR 20.04B 1.7B Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Johnson Matthey GBP 2.3B 125M Mar/2025
Linde USD 39.99B 1.89B Jun/2025
Lonza CHF 9.33B 23M Dec/2024
Merck EUR 28.26B 1.64B Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Nutrien USD 25.09B 1.05B Jun/2025
Philips EUR 10.38B 1.32B Jun/2025
PPG Industries USD 7.74B 652M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi 70.28B 3.8B Jun/2025
SAP EUR 41B 4.71B Jun/2025
Solvay EUR 1.2B 156M Jun/2025
UCB EUR 10.03B 1.08B Dec/2024
Umicore EUR 2.04B 105.8M Jun/2025
Vinci EUR 28.62B 1.33B Jun/2025